CatalymFinancing roundCatalym raises US$150mLatest NewsGerman cancer specialist Catalym GmbH has raised US$150m to finance proof-of-concept studies. Read more 15 July 2024 https://european-biotechnology.com/wp-content/uploads/2024/07/Catalym_eb.png 1080 1920 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-07-15 11:58:582024-07-16 18:21:10Catalym raises US$150m
Catalym
